Myasthenia Gravis PBMC
About: Myasthenia Gravis PBMC samples are collected from clinically confirmed Myasthenia Gravis (MG) donors and cryopreserved. These PBMCs are ideal for investigating autoreactive T and B cells, cytokine profiles, and the mechanism of MG-related antibody production.
| Lot Number | Condition | Cell Count (M) | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 75192 | Myasthenia Gravis | 10M | Caucasian | 65 | Male |
VYVGART IV infusion, scheduled every week CellCept 1500mg BID Prednisone 5mg QD Ibuprofen 400 mg BID PRN omeprazole 20mg QD
|
8 | $765.00 | ||
| 77671 | Myasthenia Gravis | 10M | Caucasian | 37 | Female |
Vyvgart infusions Mestinon 60mg 5 times daily Lyrica 100mg 3 times daily Wellbutrin 150 QD Citalopram (Celexa) 20mg omeprazole 40mg QD Otezla 30mg twice daily Symbicort inhaler 1 puff twice daily Nurtec for migraines PRN albuterol inhaler PRN birth control pill Prednisone 5 MG medical marijuana
|
10 | $765.00 | ||
| 77579 | Myasthenia Gravis | 10M | Caucasian | 54 | Male |
Vyvgart injections – Every other Monday Pepcid OTC QD CellCept 1000 mg BID Simvastatin 10 mg QD Prednisone 10 mg Tapering schedule Mestinon 60 mg QD Aspirin 81 mg Every other day Vitamin C – Daily Fish Oil – Daily Vitamin D – Daily Potassium – Daily
|
4 | $765.00 | ||
| 75385 | Myasthenia Gravis | 10M | Caucasian | 37 | Female |
Vyvgart infusions Mestinon 60mg 5 times daily Lyrica 100mg 3 times daily Wellbutrin 150 QD Citalopram (Celexa) 20mg omeprazole 40mg QD Otezla 30mg twice daily Symbicort inhaler 1 puff twice daily Nurtec for migraines PRN albuterol inhaler PRN birth control pill Cellcept 500 mg BID medical marijuana
|
1 | $765.00 | ||
| 77426 | Myasthenia Gravis | 10M | Caucasian | 33 | Female |
(IV infusion treatments- IVIG & Soliris: get at Ivx heath) **IV bard power port needle 3/4ths** *Soliris IV 1200 mg: 1 day every other week (started 10/20/2020) Vvygart Infusion start 2/9/26, weekly on Mondays x4 revaluating Tylenol (with IVIG and Soliris) Benadryl (with IVIG) IV Benadryl (with Soliris) *Amitriptyline 10 mg: 4 at night *Prednisone 10 mg: 5 in morning *Emgality: once a month on the 9th. (Started 5/9/2023) *Calcium 600 mg plus D3 20 mcg: 1 in morning *Folic acid: 1mg tablets *B12 1000 mcg: 1 in morning --As Needed Meds-- *Ubrelvy mg: as needed -Continuous Meds- *Testosterone CYP 120 mg/ .6 ml subcutaneous: once every Wednesday *Lamictal 200 mg ER: 1 in morning, 1 at night *Ritalin 20 mg: 1 pill morning, 1 pill noon *buspar 10 mg: 1 pill morning, 1 pill noon, 1 pill at night *Lexapro 20 mg: 1 in morning *Seroquel 100 mg er: 3 at night -As Needed Meds- *Lorazepam 1 mg: as needed *Hydroxyzine: as needed Amlodipine tab 10mg: 1 in morning *Topamax 50 mg: 1 in morning, 1 at night *Ropinirole HCL 3 mg: 1 at night *BIPAP: Pressure 18 over 13 *Famotidine 20 mg: 1 in morning, 1 at night --As Needed Meds-- *Ondansetron ODT 4 mg: as needed Eye gel lubricant drops- 3 times a day *Retin-A (tretinoin) cream 0.1%: at night every few days as tolerated where acne is *Clindamycin Phosphate Topical solution USP, 1%: Put on back, chest and shoulders once in morning, once at night *Finacea (azealic acid) *Ventolin HFA 90 mcg per actuation: as needed *Trimodal 50mg: as needed *Triamcinolone Acetonide ointment USP, 0.1%: as needed
|
4 | $765.00 | ||
| 70830 | Myasthenia Gravis | 10M | Hispanic/Latino | 66 | Male |
Mestinon/60mg/TID Escitalopran/10mg/QD
|
1 | $765.00 | ||
| 70794 | Myasthenia Gravis | 10M | Caucasian | 64 | Male |
Guanfacine 0.5mg QPM Zoloft 25mg QD anxiety Ropinirole 0.5mg RLS
|
3 | $765.00 | ||
| 76882 | Myasthenia Gravis | 50M | Caucasian | 65 | Male |
Mycophenolate 500mg 2 in the morning - 2 in the evening
|
75 | $1,208.00 | ||
| 70899 | Myasthenia Gravis | 50M | Asian/Pacific Islander | 71 | Female |
Escitalopram 10mg 1/day Mycophenolate Mofetil 250mg 4/day amlodipine 5mg 1/day Losartan 50mg 1/day
|
59 | $1,208.00 | ||
| 74488 | Myasthenia Gravis | 50M | Caucasian | 65 | Male |
Mycophenolate 500mg 2 in the morning - 2 in the evening
|
54 | $1,208.00 |
High-Quality Myasthenia Gravis PBMC for Research
Human Myasthenia Gravis PBMC products are sourced from donors clinically diagnosed with Myasthenia Gravis (MG) and processed under stringent conditions to support research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies of autoreactive immune cells, cytokine profiling, and production of MG-associated antibodies.
Product Features
- Research Use Only (RUO), cryopreserved PBMCs
- Clinically confirmed MG donors
- Available in cell counts ranging from 5 million to 2 billion
- Processed within 24 hours of collection
- Stored using CryoStor® CS10 freezing media
- IRB-approved protocols and electronic informed consent
- Screen LeukoLot™ available prior to bulk orders
De-identified Donor Data
- Verified MG diagnosis
- Donor demographics: age, sex assigned at birth, race/ethnicity
- Self-reported allergies and infectious disease history
- Additional Myasthenia Gravis (MG)-specific data available upon request
Applications
- Biomarker discovery and validation
- Drug screening and therapeutic development
- Immune pathway analysis in MG pathophysiology
- Transcriptomic and proteomic profiling
Quality and Compliance
- IRB-approved collections and protocols
- 21 CFR Part 11 – compliant e-consent system
- HIPAA-compliant donor data protection
Ordering & Shipping
Myasthenia Gravis (MG) PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact learnmore@sanguinebio.com to confirm documentation and compliance needs.
Protocols & Documentation
-
Download
PBMC Isolation from Whole Blood
Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.
-
Download
Immune Cell Isolation
Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.
-
Download
Choosing the Right PBMC Configuration
Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.
-
Download
Thawing Cryopreserved PBMC
Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
PBMC
Frequently Asked Questions
1 Answer
Electronic medical records are an option to be included with the PBMC sample, as well as, flow cytometry and other phenotypic testing.
1 Answer
YES – we can often accommodate treatment-naive samples including various cancers, and you can specify immunosupression status or other requirements in the I/E criteria.
1 Answer
Self-reported infectious disease testing is always available and some of our products have additional testing.
1 Answer
HLA-typing is available for some of our PBMC products.
1 Answer
YES to both – Unique donors can be specified, and multiple vials from the same donor can be arranged. You can specify these requirements when ordering.
1 Answer
Healthy PBMCs achieve over 90% vialbity post-thaw. Although our disease-state PBMCs are processed with same stringent SOP, there is more variability depending upon disease. Learn more about our post thaw viability here. https://sanguinebio.com/pbmc-viability-quality-assurance/
Ask a Question
Need a custom PBMC cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.